Menu Menu

Investors

Breakpoint is supported by an international syndicate of experienced life science investors.

MODULATING DNA DAMAGE RESPONSES TO CURE CANCER

Contact Us

Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)

Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com

Impressum

Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830

Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick

Links

Breakpoint Therapeutics GmbH @ Website by FisherPaul